A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(2 sites)

Canada

Ottawa Hospital Research Institute, Ottawa, Ontario

Montreal Neurological Institute, Montreal, Quebec